Genito-pelvic pain / penetration disorder
Crescendo was evaluated in women with GPPPD over 12 weeks using the FSFI pain domain. This is research on Crescendo, not an isolated Crescendo 2 treatment effect. The research brief explains the model distinction; positioning should follow the exact-model instructions.
See the research ↓